Kamil Faltin

Clinical Picture and Risk Factors of Severe Respiratory Symptoms in COVID-19 in Children

A. Bartkowska-Śniatkowska, J. Rosada-Kurasińska, K. Mazur-Melewska, 2021, Viruses.

Fibroblast growth factor 23 and α-Klotho serum concentration did not differ between children with autosomal dominant polycystic kidney disease and healthy controls

M. Tkaczyk, M. Pawlak-Bratkowska, P. Grzelak, 2020 .

Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic—Results of the Pediatric Part of a Multicenter Polish Register SARSTer

M. Pawłowska, B. Kalicki, L. Szenborn, 2021, Journal of clinical medicine.

Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19—analysis of a paediatric part of Polish register SARSTer

M. Pawłowska, B. Kalicki, L. Szenborn, 2021, Infectious diseases.

Effects and Safety of Convalescent Plasma Administration in a Group of Polish Pediatric Patients with COVID-19: A Case Series

P. Malecki, K. Lisowska, A. Bukowska, 2021, Life.

SARS-CoV-2 attacks the weakest point - COVID-19 course in a pediatric patient with Friedreich's ataxia

P. Malecki, W. Bobkowski, K. Mazur-Melewska, 2022, International Journal of Infectious Diseases.

12-month assessment of increase in total kidney volume in children and young adults with autosomal dominant polycystic kidney disease – a pilot study

M. Podgórski, Susan Afshari, M. Tkaczyk, 2017 .

The Influence of SARS-CoV-2 Variants B.1.1.7 and B.1.617.2 on a Different Clinical Course and Severity of COVID-19 in Children Hospitalized in 2021 Compared With 2020

M. Pawłowska, B. Kalicki, L. Szenborn, 2023, The Pediatric Infectious Disease Journal.